Fresenius Kabi
Natasha Romero is a seasoned professional with extensive experience in sales, account management, and strategic partnerships within the healthcare industry. Currently serving as Corporate Account Director at Fresenius Kabi since July 2023, Natasha previously held the position of National Director Exec. Sales and Medication Solutions Architect at BD, focusing on strategic Healthcare IDN partnerships. Prior roles include Marketing Manager at Enovate Medical and Strategic Account Executive at Covidien, where Natasha was responsible for key account management and strategic product sales. As a Certified SPIN trainer, Natasha developed sales training programs and tools for field employees, enhancing the overall sales effectiveness. Natasha holds a Bachelor of Arts in Speech Communication and Rhetoric from The University of Georgia and a Master of Science in Organizational Leadership from Colorado State University Global.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.